Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04026776

Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm

Status
Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
22 Years – 33 Years
Healthy volunteers
Accepted

Summary

The purpose of this research is to learn about how salt in the diet influences blood pressure in young adults who were born prematurely.

Detailed description

Premature birth is an emerging and important risk factor for hypertension and cardiovascular disease, as both preterm birth rates and infant survival increase worldwide. Hypertension and cardiovascular disease begin in early adulthood in individuals born prematurely, but the reasons especially in regard to the role of preterm birth are unknown. An improved understanding of why hypertension and cardiovascular disease occur in early adulthood in individuals born preterm will enable the development of prevention and treatment strategies to mitigate the burden of cardiovascular disease. Investigators propose to investigate these relationships mechanistically in a clinical trial of subjects born preterm to establish the SSBP (salt sensitivity of blood pressure) phenotype and study its relationship to CVD (cardiovascular disease) compared to a control group of healthy term- born peers. Investigators will then propose to determine if blocking UA (uric acid) formation improves SSBP and cardiovascular function in subjects born preterm.

Conditions

Interventions

TypeNameDescription
DRUGAllopurinolStudy Part 2- Preterm group only: After Visit 5 preterm born participants will start allopurinol 200 mg daily PO for 6 weeks. The 1 week high and low salt diets and assessments will be repeated while on allopurinol.
OTHERDietary InterventionHigh-Na+ (250 mmol/d) and low-Na+ (50 mmol/d) standard isocaloric K+ diets (75 mmol/1000 kcal/d) for 1 week each as 3 meals and 1 snack a day provided by the Clinical Research Unit Metabolic Kitchen. Part 2 preterm only- the diets will be repeated while the participant is taking allopurinol.

Timeline

Start date
2020-09-02
Primary completion
2026-06-01
Completion
2026-06-01
First posted
2019-07-19
Last updated
2026-04-01

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04026776. Inclusion in this directory is not an endorsement.